Symbol
| APOM
| contributors: mct - updated : 24-01-2020
|
HGNC name
| apolipoprotein M
|
HGNC id
| 13916
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --low
|  
|
in patients with type 2 diabetes mellitus  | constitutional
|  
|  
| --low
|  
|
plasma APOM levels were reduced in patients with chronic kidney disease (CKD) stages 3-5D as compared to patients with CKD stages 1 + 2 and controls  | tumoral
|  
|  
| --over
|  
|
mRNA levels in the colorectal cancer tissues were significantly increased in the patients with lymph node metastasis  | tumoral
|  
|  
| --low
|  
|
in hepatocellular carcinoma tissues  | |
Susceptibility
|
to venous thromboembolism (VTE) |
Variant & Polymorphism
| APOM rs805297 was significantly associated with higher risk of VTE recurrence in male but not in female patients  |
|
|
Candidate gene
Marker
| potential for APOM/S1P as biomarkers for inflammation, sepsis and nephropathy  | Therapy target
| | |
| lack of Apom in mice increases the amount of brown adipose tissue (BAT), accelerates the clearance of postprandial triglycerides, and protects against diet-induced obesity  |